Mangoceuticals Inc.
13F holders, Q2 2024 (June 30)6holders −2
2new positions
4sold out
1famous investor
$0.31avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Mangoceuticals Inc. in their 13F filings, down 2 from Q1 2024. 2 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($41K), Mercer Global Advisors Inc. ($30K) and Virtu Financial LLC ($30K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Mangoceuticals Inc.
- CUSIP
- 56270V106
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $57K |
| Exits | 4 | $19K |
All 13F filers, Q1 2024 → Q2 2024: 244,335 shares bought and 89,252 shares sold, net +155,083 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Citadel Advisors | 0.00% | Add +16.4% | 133,195 | $41K |
| Mercer Global Advisors Inc. | 0.00% | No change | 100,000 | $30K |
| Virtu Financial LLC | 0.00% | New | 98,697 | $30K |
| PEAK6 Investments LLC | 0.00% | New | 88,349 | $27K |
| UBS Group AG | 0.00% | Add +266.5% | 52,944 | $16K |
| Morgan Stanley | 0.00% | No change | 10,358 | $3K |
"% of holder's portfolio" is MANGOCEUTICALS INC's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.